HomeALNEV • EPA
add
Neovacs SA
Previous close
€1.00
Day range
€0.88 - €1.00
Year range
€0.88 - €32,000.00
Market cap
136.43K EUR
Avg Volume
6.76K
P/E ratio
-
Dividend yield
-
Primary exchange
EPA
Market news
Financials
Income Statement
Revenue
Net income
| (EUR) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 196.20K | 283.31% |
Operating expense | 1.20M | 34.51% |
Net income | -15.50M | -623.57% |
Net profit margin | -7.90K | -88.77% |
Earnings per share | — | — |
EBITDA | -1.73M | 3.64% |
Effective tax rate | 1.44% | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 231.61K | -96.26% |
Total assets | 43.92M | -22.93% |
Total liabilities | 25.29M | 227.59% |
Total equity | 18.63M | — |
Shares outstanding | — | — |
Price to book | — | — |
Return on assets | -10.15% | — |
Return on capital | -23.32% | — |
Cash Flow
Net change in cash
| (EUR) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -15.50M | -623.57% |
Cash from operations | -1.47M | 13.21% |
Cash from investing | 857.26K | 160.84% |
Cash from financing | 285.01K | -89.27% |
Net change in cash | -327.74K | 26.65% |
Free cash flow | -1.10M | 27.60% |
About
Founded
1993
Website
Employees
22
